These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 39269960)

  • 21. Variation in textural parameters of hepatic lesions during contrast medium injection.
    Zhang YH; Brehmer K; Svensson A; Herlin G; Stål P; Brismar TB
    Acta Radiol; 2021 Oct; 62(10):1317-1323. PubMed ID: 33108894
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Machine learning-based identification of contrast-enhancement phase of computed tomography scans.
    Guha S; Ibrahim A; Wu Q; Geng P; Chou Y; Yang H; Ma J; Lu L; Wang D; Schwartz LH; Xie CM; Zhao B
    PLoS One; 2024; 19(2):e0294581. PubMed ID: 38306329
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Image quality of mean temporal arterial and mean temporal portal venous phase images calculated from low dose dynamic volume perfusion CT datasets in patients with hepatocellular carcinoma and pancreatic cancer.
    Wang X; Henzler T; Gawlitza J; Diehl S; Wilhelm T; Schoenberg SO; Jin ZY; Xue HD; Smakic A
    Eur J Radiol; 2016 Nov; 85(11):2104-2110. PubMed ID: 27776665
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reproducibility for Hepatocellular Carcinoma CT Radiomic Features: Influence of Delineation Variability Based on 3D-CT, 4D-CT and Multiple-Parameter MR Images.
    Duan J; Qiu Q; Zhu J; Shang D; Dou X; Sun T; Yin Y; Meng X
    Front Oncol; 2022; 12():881931. PubMed ID: 35494061
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Magnetic Resonance Deep Learning Radiomic Model Based on Distinct Metastatic Vascular Patterns for Evaluating Recurrence-Free Survival in Hepatocellular Carcinoma.
    Zhang C; Ma LD; Zhang XL; Lei C; Yuan SS; Li JP; Geng ZJ; Li XM; Quan XY; Zheng C; Geng YY; Zhang J; Zheng QL; Hou J; Xie SY; Lu LH; Xie CM
    J Magn Reson Imaging; 2024 Jul; 60(1):231-242. PubMed ID: 37888871
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of renal masses with MRI-based radiomics: assessment of inter-package and inter-observer reproducibility in a prospective pilot study.
    Al-Mubarak H; Bane O; Gillingham N; Kyriakakos C; Abboud G; Cuevas J; Gonzalez J; Meilika K; Horowitz A; Huang HV; Daza J; Fauveau V; Badani K; Viswanath SE; Taouli B; Lewis S
    Abdom Radiol (NY); 2024 Oct; 49(10):3464-3475. PubMed ID: 38467854
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of hepatocellular carcinoma by Gd-EOB-DTPA-enhanced liver MRI: comparison with triple phase 64 detector row helical CT.
    Akai H; Kiryu S; Matsuda I; Satou J; Takao H; Tajima T; Watanabe Y; Imamura H; Kokudo N; Akahane M; Ohtomo K
    Eur J Radiol; 2011 Nov; 80(2):310-5. PubMed ID: 20732773
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Using receiver operating characteristic curves to evaluate the diagnostic value of the combination of multislice spiral CT and alpha-fetoprotein levels for small hepatocellular carcinoma in cirrhotic patients.
    Jia GS; Feng GL; Li JP; Xu HL; Wang H; Cheng YP; Yan LL; Jiang HJ
    Hepatobiliary Pancreat Dis Int; 2017 Jun; 16(3):303-309. PubMed ID: 28603099
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of Lipiodol uptake in angiography and computed tomography for the diagnosis of malignant versus benign hepatocellular nodules in cirrhotic liver.
    Langenbach MC; Vogl TJ; von den Driesch I; Kaltenbach B; Scholtz JE; Hammerstingl RM; Gruber-Rouh T
    Eur Radiol; 2019 Dec; 29(12):6539-6549. PubMed ID: 31236701
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimal phases of dynamic CT for detecting hepatocellular carcinoma: evaluation of unenhanced and triple-phase images.
    Kim T; Murakami T; Takahashi S; Tsuda K; Tomoda K; Narumi Y; Oi H; Sakon M; Nakamura H
    Abdom Imaging; 1999; 24(5):473-80. PubMed ID: 10475931
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contrast-enhanced computed tomography plus gadolinium-ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging for gross classification of hepatocellular carcinoma.
    Chen C; Zhao H; Fu X; Huang L; Tang M; Yan X; Sun S; Jia W; Mao L; Shi J; Chen J; He J; Zhu J; Qiu Y
    Oncotarget; 2017 May; 8(18):29741-29750. PubMed ID: 28392502
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CT-based radiomics signature: a potential biomarker for preoperative prediction of early recurrence in hepatocellular carcinoma.
    Zhou Y; He L; Huang Y; Chen S; Wu P; Ye W; Liu Z; Liang C
    Abdom Radiol (NY); 2017 Jun; 42(6):1695-1704. PubMed ID: 28180924
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CT radiomic features reproducibility of virtual non-contrast series derived from photon-counting CCTA datasets using a novel calcium-preserving reconstruction algorithm compared with standard non-contrast series: focusing on epicardial adipose tissue.
    Cui M; Bao S; Li J; Dong H; Xu Z; Yan F; Yang W
    Int J Cardiovasc Imaging; 2024 Jun; 40(6):1257-1267. PubMed ID: 38587689
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Short-term reproducibility of radiomic features in liver parenchyma and liver malignancies on contrast-enhanced CT imaging.
    Perrin T; Midya A; Yamashita R; Chakraborty J; Saidon T; Jarnagin WR; Gonen M; Simpson AL; Do RKG
    Abdom Radiol (NY); 2018 Dec; 43(12):3271-3278. PubMed ID: 29730738
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiple-phase helical CT of the liver for detecting small hepatomas in patients with liver cirrhosis: contrast-injection protocol and optimal timing.
    Mitsuzaki K; Yamashita Y; Ogata I; Nishiharu T; Urata J; Takahashi M
    AJR Am J Roentgenol; 1996 Sep; 167(3):753-7. PubMed ID: 8751695
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction early recurrence of hepatocellular carcinoma eligible for curative ablation using a Radiomics nomogram.
    Yuan C; Wang Z; Gu D; Tian J; Zhao P; Wei J; Yang X; Hao X; Dong D; He N; Sun Y; Gao W; Feng J
    Cancer Imaging; 2019 Apr; 19(1):21. PubMed ID: 31027510
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intratumoral artery on contrast-enhanced computed tomography imaging: differentiating intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma.
    Tsunematsu S; Chuma M; Kamiyama T; Miyamoto N; Yabusaki S; Hatanaka K; Mitsuhashi T; Kamachi H; Yokoo H; Kakisaka T; Tsuruga Y; Orimo T; Wakayama K; Ito J; Sato F; Terashita K; Nakai M; Tsukuda Y; Sho T; Suda G; Morikawa K; Natsuizaka M; Nakanishi M; Ogawa K; Taketomi A; Matsuno Y; Sakamoto N
    Abdom Imaging; 2015 Aug; 40(6):1492-9. PubMed ID: 25579172
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiomics Based on Contrast-Enhanced CT for Recognizing c-Met-Positive Hepatocellular Carcinoma: a Noninvasive Approach to Predict the Outcome of Sorafenib Resistance.
    Gu J; Bao S; Akemuhan R; Jia Z; Zhang Y; Huang C
    Mol Imaging Biol; 2023 Dec; 25(6):1073-1083. PubMed ID: 37932610
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differences Between CT-Perfusion and Biphasic Contrast-enhanced CT for Detection and Characterization of Hepatocellular Carcinoma: Potential Explanations for Discrepant Cases.
    Perl RM; Portugall J; Hinterleitner C; Hinterleitner M; Kloth C; Walter SS; Bitzer M; Horger MS
    Anticancer Res; 2021 Mar; 41(3):1451-1458. PubMed ID: 33788737
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multidetector CT with double arterial phase and high-iodine-concentration contrast agent in the detection of hepatocellular carcinoma.
    Pozzi Mucelli RM; Como G; Del Frate C; Iuri D; Furlan A; Al-Grhiw E; Bazzocchi M
    Radiol Med; 2006 Mar; 111(2):181-91. PubMed ID: 16671376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.